Head & Neck/Thyroid Cancers
Perspectives
Diagnosed too late
We take a course in giving bad news, but every doctor has his or her own approach.
Conference Coverage
Immunotherapy may be path forward in HPV oropharyngeal cancer
Immunotherapy benefits locally advanced HPV-positive oropharyngeal cancer in phase 2 study.
Commentary
Discontinuing immunotherapy: Is the infusion bag half empty or half full?
Clinical trials of immunotherapy or chemoimmunotherapy have generally terminated treatment in nonprogressing patients after 2 years.
Conference Coverage
How AI is, or will soon be, relevant in radiation oncology
Radiation oncologists at ASTRO 2022 discuss practical applications of AI, and new research findings.
From the Journals
Chronic stress, especially race related, may hasten cancer death
High allostatic load was associated with an 80% increased risk of cancer death among all study participants.
From the Journals
Third COVID booster benefits cancer patients
For the first time, researchers have quantified the benefits of boosters for COVID-19 in cancer patients.
Feature
Glioblastoma spreading strategies discovered
The more-or-less specific interaction between the nerve cells and the tumor cells also offers starting points for therapies, from our point of...
From the Journals
Novel co-admin of CAR T cells achieves 99% remission in leukemia
“We do believe [this approach] will become standard of care.”
Conference Coverage
ctDNA hints at esophageal cancer outcomes
Reductions in ctDNA were associated with better progression-free and overall survival.
Latest News
New EU guidelines: Individualize care for thyroid cancer in kids
Pediatric differentiated thyroid carcinoma “is not adult DTC in a small person; it has different genetics and a different clinical behavior.”
From the Journals
Safe to expand limits of active surveillance in thyroid cancer?
Raising the limits for tumor size and growth showed no increase in adverse outcomes or mortality.